Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Nephrocare Health Services Limited (NSE: NEPHROPLUS), ISIN INE428V01029 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
NEPHROPLUS last traded at ₹617.50 (+2.62%), with a 52-week range of ₹446.00 to ₹781.50 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 58.31%, FIIs 11.73%, DIIs 8.11%, mutual funds 3.93%.
EquiSense Score (ECS): 69/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.